Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Morgan M. Eikanger
Observed name:
Morgan Eikanger
Institution:
University of South Dakota
Observed institution:
University of South Dakota
ORCID:
0000-0002-6435-6175
Observed ORCID:
0000-0002-6435-6175
OpenAlex ID:
A5041383288
Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles
2023
·
Nisitha Wijewantha
, Sanam Sane
, et al.
·
Cancers
·
32
PDF
UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer
2023
·
Sanam Sane
, Rekha Srinivasan
, et al.
·
Oncogene
·
29
PDF
Targeting Colon Cancer Cells with Enzyme-Triggered Casein-Gated Release of Cargo from Mesoporous Silica-Based Nanoparticles
2021
·
Nisitha Wijewantha
, Morgan M. Eikanger
, et al.
·
Bioconjugate Chemistry
·
26
Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model
2022
·
Jessica L. Freeling
, Jamie L. Scholl
, et al.
·
Cell Death Discovery
·
11
PDF
Liver-Specific Nanoparticle-Mediated Delivery and MMP-Triggered Release of Veratridine to Effectively Target Metastatic Colorectal Cancer
2025
·
Mahadi Hasan
, Morgan Eikanger
, et al.
·
Cancers
·
3
PDF
Veratridine, a plant-derived alkaloid, suppresses the hyperactive Rictor-mTORC2 pathway: a new targeted therapy for primary and metastatic colorectal cancer
2024
·
Morgan M. Eikanger
, Sanam Sane
, et al.
·
Research Square
·
3
PDF
Abstract 5768: Repurposing veratridine, a previously used antihypertensive supplement, for effective treatment of metastatic colorectal cancer
2026
·
Morgan Eikanger
, Khosrow S. Rezvani
·
Cancer Research
Abstract C087: Drugging UBXN2A, a tumor suppressor protein in colorectal cancer: Selective suppression of mTORC2-AKT pathway in patient-derived xenograft cells
2025
·
Morgan Montgomery
, Morgan Eikanger
, et al.
·
Molecular Cancer Therapeutics
Abstract 3027: Killing two birds with one stone: veratridine functions as a dual inhibitor of both hyperactive mTORC2 and mitochondria in colon cancer cells
2025
·
Morgan Eikanger
, Khosrow Rezvani
·
Cancer Research
Abstract 1318: Cytotoxic effect of plant-based alkaloid veratridine on patient-derived colorectal cancer spheroid cells
2025
·
Kate Schraufnagel
, Morgan Eikanger
, et al.
·
Cancer Research
Targeted delivery of eugenol by enzyme-responsive mesoporous silica nanoassemblies for colorectal cancer therapy
2023
·
Nisitha Wellala Wijewantha
, Sanam Sane
, et al.
Smart mesoporous silica nanoparticles-based stimuli-responsive nanocarriers for the controlled delivery of veratridine, an anti-cancer molecule for targeting colon cancer cells
2022
·
Nisitha Wellala Wijewantha
, Morgan Eikanger
, et al.
Abstract 3934: UBXN2A inhibits tumor invasion and metastasis by targeting the mTORC2-VEGF pathway
2020
·
Morgan Eikanger
, Rekha Srinivasan
, et al.
·
Cancer Research
UBXN2A Inhibits Tumor Invasion and Metastasis by Targeting the mTORC2-VEGF Pathway
2020
·
Morgan Eikanger
Show more works
View as search
Works count:
14
Citation count:
104
H-index:
4
I10-index:
4
Year
Topic
Type